Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Connexin43 peptide, TAT-Cx43266–283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-12-27
DOI
10.1093/neuonc/noz243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Connexins in cancer: bridging the gap to the clinic
- (2019) Trond Aasen et al. ONCOGENE
- Targeting MAPK phosphorylation of Connexin43 provides neuroprotection in stroke
- (2019) Moises Freitas-Andrade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The connexin 43 C-terminus: A tail of many tales
- (2018) Edward Leithe et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Therapeutic strategies targeting connexins
- (2018) Dale W. Laird et al. NATURE REVIEWS DRUG DISCOVERY
- A c-Src Inhibitor Peptide Based on Connexin43 Exerts Neuroprotective Effects through the Inhibition of Glial Hemichannel Activity
- (2017) Ester Gangoso et al. Frontiers in Molecular Neuroscience
- A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK
- (2017) Myriam Jaraíz-Rodríguez et al. Stem Cell Reports
- Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer
- (2016) Qing Chen et al. NATURE
- CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study
- (2016) Viveka Nand Yadav et al. Oncotarget
- Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes
- (2016) Ana González-Sánchez et al. Oncotarget
- Expression of a gap junction protein, connexin43, in a large panel of human gliomas: new insights
- (2016) Sophie Crespin et al. Cancer Medicine
- Targeting SOX2 as a Therapeutic Strategy in Glioblastoma
- (2016) Laura Garros-Regulez et al. Frontiers in Oncology
- Nestin as a marker of cancer stem cells
- (2015) Jakub Neradil et al. CANCER SCIENCE
- Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
- (2015) Jean-Michel Lemée et al. NEURO-ONCOLOGY
- Astrocytes promote glioma invasion via the gap junction protein connexin43
- (2015) W C Sin et al. ONCOGENE
- Differential Connexin Function Enhances Self-Renewal in Glioblastoma
- (2015) Masahiro Hitomi et al. Cell Reports
- The role of Src family kinases in growth and migration of glioma stem cells
- (2014) XIAOSI HAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms of Glioma Formation: Iterative Perivascular Glioma Growth and Invasion Leads to Tumor Progression, VEGF-Independent Vascularization, and Resistance to Antiangiogenic Therapy
- (2014) Gregory J. Baker et al. NEOPLASIA
- Implantation of GL261 neurospheres into C57/BL6 mice: A more reliable syngeneic graft model for research on glioma-initiating cells
- (2013) LIANG YI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Regulation of the Src Family Kinases by Csk
- (2012) Masato Okada International Journal of Biological Sciences
- Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial
- (2012) Michael D Hill et al. LANCET NEUROLOGY
- EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer
- (2012) Sandeep Singh et al. Molecular Cancer
- A restricted cell population propagates glioblastoma growth after chemotherapy
- (2012) Jian Chen et al. NATURE
- Elevated invasive potential of glioblastoma stem cells
- (2011) Lin Cheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Connexin 43 Reverses Malignant Phenotypes of Glioma Stem Cells by Modulating E-Cadherin
- (2011) Shi-Cang Yu et al. STEM CELLS
- Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas
- (2010) Juan L Garcia et al. BMC CANCER
- 2,3-Sialylation regulates the stability of stem cell marker CD133
- (2010) F. Zhou et al. JOURNAL OF BIOCHEMISTRY
- Oleic acid synthesized in the periventricular zone promotes axonogenesis in the striatum during brain development
- (2010) Erica Polo-Hernández et al. JOURNAL OF NEUROCHEMISTRY
- Brain tumor stem cells: The cancer stem cell hypothesis writ large
- (2010) Peter B. Dirks Molecular Oncology
- Astroglial networks: a step further in neuroglial and gliovascular interactions
- (2010) Christian Giaume et al. NATURE REVIEWS NEUROSCIENCE
- Connexin43 inhibits the oncogenic activity of c-Src in C6 glioma cells
- (2010) S Herrero-González et al. ONCOGENE
- Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
- (2009) Steven M. Pollard et al. Cell Stem Cell
- Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
- (2008) Q Chang et al. BRITISH JOURNAL OF CANCER
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapy
- (2008) Jinyan Du et al. NATURE BIOTECHNOLOGY
- SOX2Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of Tumorigenicity
- (2008) Rosaria Maria Rita Gangemi et al. STEM CELLS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search